Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03012191Phase 1/2Completed
Gentamicin for RDEB
Recessive Dystrophic Epidermolysis Bullosa
PrincipalinvestigatorStart date: 2017-02-02
NCT02698735Phase 1/2Completed
Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients
Recessive Dystrophic Epidermolysis Bullosa
PrincipalinvestigatorStart date: 2016-02-25

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Southern California Department of Dermatology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jean Y Tang, PhD

Stanford University

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Elena Pope, MD, FRCPC

The Hospital for Sick Children

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Alain Hovnanian, Prof

National Institut of health and medical research

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

John A McGrath, FRCP

King's College London

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Neda Nikbakht, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

John McGrath, FRCP/FSci/MD

King's College London

Moderately Similar
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Johann W. Bauer, MD

Paracelsus Medical University - EB House

Moderately Similar
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Michele De Luca, MD/Professor

Holostem s.r.l.

Moderately Similar
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Sarah Abdelwahab, MD

Abeona Therapeutics, Inc

Moderately Similar
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Jean Tang, MD

Stanford University

Moderately Similar
2 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03012191Phase 1/2PrincipalInvestigator

Gentamicin for RDEB

Recessive Dystrophic Epidermolysis Bullosa
Completed
NCT02698735Phase 1/2PrincipalInvestigator

Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients

Recessive Dystrophic Epidermolysis Bullosa
Completed

All 2 trials loaded